Human liver-resident CD56bright/CD16neg NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways
Introduction
Natural killer (NK) cells are important effectors of the innate immune system that can lyse tumor-transformed or virus-infected cells in the absence of prior antigen sensitization. NK cells are also endowed with immune-regulatory functions at tissue sites of inflammation through the establishment of cellular interactions and the production of pro-inflammatory cytokines including IFN-γ, TNF-α, CCL3 (Mip1-α), CCL4 (Mip1-β)and CCL5 (RANTES) [1], [2]. Human peripheral blood NK (PB-NK) cells are divided into two functionally distinct subsets characterized by a different distribution of CD56 and CD16 surface markers. CD56bright/CD16neg-low (CD56bright) NK cells account for 5–15% of all PB-NK cells and, while poorly cytotoxic, can produce large amounts of cytokines. CD56dim/CD16pos (CD56dim) NK cells represent the majority of PB-NK cells (up to 95%) and serve primarily as cytotoxic effectors [3]. In order to spare autologous cells from cytotoxicity and ensure tolerance to self, NK cells receive inhibitory signals from a large family of inhibitory NK cell receptors (iNKRs), that include Killer cell immunoglobulin-like receptors (KIRs) and C-type lectins recognizing specific alleles of self MHC-class-I molecules (MHC-I). NK cell effector-functions are generally induced by the engagement of another family of activating NK cell receptors (aNKRs) that binds their ligands expressed on stressed, infected or tumor-transformed target cells that either lack or have a decreased expression of self-MHC-I [1], [4], [5], [6].
NK cells can account up to 50% of the total lymphocyte population in the human liver, which is in contrast to their lower frequency in blood (5–15%) or other peripheral tissues such as lymph nodes. Hence, great efforts have been placed over the recent years to understand the role of hepatic NK cells in the pathogenesis of liver disorders including fibrosis, viral infections, tumors and autoimmune diseases [7], [8], [9]. In this regard, a distinct subset of hepatic NK cells endowed with adaptive immune properties and exhibiting antigen-specific recall responses to viruses and haptens has been recently described in mice [10], [11]. This memory-like response is exerted by a unique subset of CD49apos/DX5neg liver-resident NK (lr-NK) cells that are phenotypically and functionally distinct from peripheral blood CD49aneg/DX5pos conventional NK (c-NK) cells circulating throughout spleen and liver. Likewise, it has been reported that NK cells in human liver are different from their circulating counterparts [7], [12], [13], [14], [15], [16], thus suggesting that a unique lr-NK cell subset also exists in the human liver under homeostatic conditions. However, the overall frequency and the precise phenotype of human lr-NK cells are still being debated, while the distribution and the homing mechanisms regulating their retention in the liver are unknown. The present study characterizes CD56bright lr-NK cells selectively located within hepatic sinusoids and accounting for half of the entire hepatic NK cell population. We demonstrate that CD56bright lr-NK cells are phenotypically and transcriptionally distinct from PB-CD56bright NK cells and constitutively express high levels of markers associated with tissue residency including CD69, CCR5 and CXCR6. This unique phenotype is functionally relevant as CD56bright lr-NK cells migrate in response to CCL3, CCL5 and CXCL16, the CCR5 and CXCR6 ligands highly expressed within liver sinusoids on Kupffer cells, T and NK lymphocytes as well as endothelial cells.
Section snippets
Human donors
Human peripheral blood mononuclear cells (PBMCs) were isolated from buffy coats of healthy donors obtained in accordance with clinical protocols approved by the Institutional Review Board of Desio Hospital, Milan, Italy. Liver specimens were obtained from patients undergoing liver resection to remove liver metastases of colorectal carcinoma. Fragments of hepatic tissues used for our experiments were macroscopically and microscopically free of any diseases and considered healthy, as assessed by
CD56bright hepatic NK cells are enriched at high frequencies in the healthy human liver
Similar to their circulating counterparts, human hepatic NK cells can be distinguished into two CD56pos/CD16neg and CD56pos/CD16pos cell subsets under homeostatic conditions [3], [19]. However, the frequency of CD56pos/CD16neg hepatic NK cells is significantly higher compared to that of CD56pos/CD16neg PB-NK cells in matched donors [7], [22] (Fig. 1A and C). CD56pos/CD16neg PB-NK cells are conventionally defined as CD56bright NK cells due to the higher mean fluorescence intensity (MFI) of CD56
Discussion
The present study characterizes a novel subset of CD56bright lr-NK cells, whose transcriptional and phenotypic profiles differ from those of its circulating counterparts. We show that CD56bright lr-NK cells constitutively express markers of tissue-residency including CD69, CCR5 and CXCR6. The unique repertoire of chemokine receptors on CD56bright lr-NK cells is functionally relevant as this subset selectively migrates in response to the chemotactic stimuli given by CCR5 (i.e. CCL3 and CCL5) and
Author contributions
Conception and design: K.H. and D.M; Contributed unpublished, essential data, or reagents (recruited patients for liver specimens): M.D., M.C. and G.T.; Contributed unpublished, essential data, or reagents (recruited patients for liver-perfusate specimens): M.H. and A.B; Acquisition of data, analysis and interpretation of data: K.H., E.P., P.T., M.P., S.B., P.I., E.L., M.E.G., D.M. K.H. and D.M.; Drafting the article: K.H. and D.M.
Conflict of interest
The authors have declared that no conflict of interest exists.
Acknowledgments
We are deeply grateful to all human donors and patients participating to this study for their generosity and support. This work was supported by the Italian Ministry of Health (Bando Giovani Ricercatori, GR-2008-1135082 to D.M.), Italian Association for Cancer Research (AIRC IG 14687 to D.M.), the European Union (Marie Curie International Reintegration Grant 322093 to E.L.), the National Institutes of Health (DK39588 to M.E.G.) and by the intramural research program of Humanitas Clinical and
References (75)
- et al.
The biology of human natural killer-cell subsets
Trends Immunol.
(2001) - et al.
The role of natural killer cells in autoimmune liver disease: a comprehensive review
J. Autoimmun.
(2013) - et al.
Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes
J. Hepatol.
(2003) - et al.
Engagement of NKp30 on Vdelta1 T cells induces the production of CCL3, CCL4, and CCL5 and suppresses HIV-1 replication
Blood
(2012) - et al.
Targeted lysis of HIV-infected cells by natural killer cells armed and triggered by a recombinant immunoglobulin fusion protein: implications for immunotherapy
Virology
(2005) - et al.
Intrahepatic interleukin-8 production during disease progression of chronic hepatitis C
Cancer Lett.
(2007) - et al.
Isolation of lymphocytes from normal adult human liver suitable for phenotypic and functional characterization
J. Immunol. Methods
(2000) - et al.
Human liver transplant perfusate: an abundant source of donor liver-associated leukocytes
Hepatology
(1997) - et al.
TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver
Blood
(2005) - et al.
Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes
Am. J. Pathol.
(2002)
Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets
Immunity
A new approach to isolation and culture of human Kupffer cells
J. Immunol. Methods
Ccr5 deficiency regulates the proliferation and trafficking of natural killer cells under physiological conditions
Cytokine
A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells
Immunity
NK cell and DC interactions
Trends Immunol.
Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses
Blood
Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1, and ICAM-3
Blood
Location and cellular stages of natural killer cell development
Trends Immunol.
Identification of the earliest natural killer cell-committed progenitor in murine bone marrow
Blood
A population of early fetal thymocytes expressing Fc gamma RII/III contains precursors of T lymphocytes and natural killer cells
Cell
Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells
Gastroenterology
Clinical features and pathobiology of Ebolavirus infection
J. Autoimmun.
Myasthenia Gravis: paradox versus paradigm in autoimmunity
J. Autoimmun.
From defining antigens to new therapies in multiple sclerosis: honoring the contributions of Ruth Arnon and Michael Sela
J. Autoimmun.
Innate or adaptive immunity? the example of natural killer cells
Science
NK cell subset redistribution during the course of viral infections
Front. Immunol.
NK cell recognition
Annu. Rev. Immunol.
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
Annu. Rev. Immunol.
Controlling natural killer cell responses: integration of signals for activation and inhibition
Annu. Rev. Immunol.
Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections
Gastroenterology
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
Nat. Med.
Liver-resident NK cells confer adaptive immunity in skin-contact inflammation
J. Clin. Invest.
Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses
Nat. Immunol.
Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients
Hepatology
Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans
Hepatology
Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virus
Eur. J. Immunol.
Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells
J. Immunol.
Cited by (195)
Are innate lymphoid cells friend or foe in human pregnancy?
2024, American Journal of Reproductive ImmunologySerum CXCL16: A new predictor of liver inflammation in patients with chronic hepatitis B
2024, Journal of Viral HepatitisTissue-resident memory NK cells: Homing in on local effectors and regulators
2024, Immunological ReviewsIL-2-mediated hepatotoxicity: knowledge gap identification based on the irAOP concept
2024, Journal of Immunotoxicology